Table 1 Patients' characteristics
Baseline characteristics of all patients (n = 45) | Patients who were eligible for BCS (n = 36) | |||
|---|---|---|---|---|
N | % | N | % | |
Age at diagnosis | ||||
< 50 | 27 | 60 | 22 | 61.1 |
≥50 | 18 | 40 | 14 | 38.9 |
Tumour size | ||||
≤5 cm | 4 | 8.9 | 4 | 11.1 |
> 5 cm | 41 | 91.1 | 32 | 88.9 |
Tumour site | ||||
Upper outer quadrant | 32 | 71.1 | 26 | 72.2 |
Lower outer quadrant | 9 | 20 | 7 | 19.4 |
Upper inner quadrant | 4 | 8.9 | 3 | 8.3 |
Laterality | ||||
Right sided | 24 | 53.3 | 19 | 52.8 |
Left sided | 21 | 46.7 | 17 | 47.2 |
Clinical staging | ||||
T3N0 | 10 | 22.2 | 8 | 22.2 |
T3N1 | 25 | 55.6 | 20 | 55.6 |
T3N2 | 6 | 13.3 | 4 | 11.1 |
T2N2 | 4 | 8.9 | 4 | 11.1 |
Histologic grade | ||||
Grade II | 30 | 66.7 | 25 | 69.4 |
Grade III | 15 | 33.3 | 11 | 30.6 |
Hormonal status (HR) | ||||
HR positive | 37 | 82.2 | 30 | 83.3 |
HR negative | 8 | 17.8 | 6 | 16.7 |
Total | 45 | 100 | 36 | 100 |